Company
Akribion
RNA-guided cell depletion
Also known as Akribion Therapeutics, Akribion Therapeutics GmbH
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Zwingenberg, Germany
- Founded
- 2024
- Legal name
- Akribion Therapeutics GmbH
- akribion-therapeutics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Akribion Therapeutics is developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion.
Funding snapshot
- Latest round
- Seed
Funding rounds
- Seed
- Recorded
Loading relationship preview